| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Infant Bacterial Therapeutics AB (publ) (ST: IBT-B)
IBT-B Technical Analysis
2
| As on 2nd Sep 2025 IBT-B STOCK Price closed @ 75.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 68.46 & Strong Sell for SHORT-TERM with Stoploss of 86.92 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IBT-BSTOCK Price
| Open | 77.60 | Change | Price | % |
| High | 77.80 | 1 Day | -3.90 | -4.94 |
| Low | 70.50 | 1 Week | 22.00 | 41.51 |
| Close | 75.00 | 1 Month | 24.00 | 47.06 |
| Volume | 25857 | 1 Year | -3.60 | -4.58 |
| 52 Week High 124.50 | 52 Week Low 31.60 | ||||
ST Sweden Most Active Stocks
| ENERS | 0.00 | % |
| FING-B | 0.01 | 0.00% |
| IMMNOV | 0.73 | -6.41% |
| LIPI | 0.22 | -4.35% |
| WYLD | 0.01 | 0.00% |
| QUIA | 0.00 | % |
| LUNE | 21.97 | 6.65% |
| POLY | 0.04 | 0.00% |
| XBRANE | 0.28 | 0.00% |
| SBB-B | 4.64 | -4.33% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
| IBT-B Daily Charts |
IBT-B Intraday Charts |
Whats New @ Bazaartrend |
IBT-B Free Analysis |
|
|
IBT-B Important Levels Intraday
| RESISTANCE | 89.07 |
| RESISTANCE | 84.56 |
| RESISTANCE | 81.77 |
| RESISTANCE | 78.98 |
| SUPPORT | 71.02 |
| SUPPORT | 68.23 |
| SUPPORT | 65.44 |
| SUPPORT | 60.93 |
IBT-B Forecast September 2025
| 4th UP Forecast | 121.63 |
| 3rd UP Forecast | 106.68 |
| 2nd UP Forecast | 97.43 |
| 1st UP Forecast | 88.19 |
| 1st DOWN Forecast | 61.81 |
| 2nd DOWN Forecast | 52.57 |
| 3rd DOWN Forecast | 43.32 |
| 4th DOWN Forecast | 28.37 |
IBT-B Weekly Forecast
| 4th UP Forecast | 93.11 |
| 3rd UP Forecast | 87.30 |
| 2nd UP Forecast | 83.71 |
| 1st UP Forecast | 80.12 |
| 1st DOWN Forecast | 69.88 |
| 2nd DOWN Forecast | 66.29 |
| 3rd DOWN Forecast | 62.70 |
| 4th DOWN Forecast | 56.89 |
IBT-B Forecast2025
| 4th UP Forecast | 293.33 |
| 3rd UP Forecast | 223.31 |
| 2nd UP Forecast | 180.03 |
| 1st UP Forecast | 136.75 |
| 1st DOWN Forecast | 13.25 |
| 2nd DOWN Forecast | -30.03 |
| 3rd DOWN Forecast | -73.31 |
| 4th DOWN Forecast | -143.33 |
Infant Bacterial Therapeutics AB (publ) ( ST Sweden Symbol : IBT-B )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IBT-B Business Profile
Infant Bacterial Therapeutics AB (publ), a clinical stage pharmaceutical company, develops drugs to prevent or treat rare diseases affecting infants. The company's lead drug candidate is IBP-9414, to prevent necrotizing enterocolitis, as well as to improve feeding tolerance affecting premature infants. It is also developing IBP-1016 for the treatment of an unmet medical need in gastroschisis, a severe disease in infants. The company was founded in 2013 and is based in Stockholm, Sweden. Address: Bryggargatan 10, Stockholm, Sweden, 111 21
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service